Skip to main content
Home
FULL MENU Close Menu
Home
Home

Neil Osterweil

News

Triplet shows ‘promising’ activity in unresectable/metastatic CRC

Author:
Neil Osterweil
Publish date: January 22, 2021

Panitumumab plus ipilimumab and nivolumab induced responses in more than a third of patients.

  • Read More

Article

Coronasomnia: Pervasive sleeplessness, self-medicating raise concerns of sleep experts

Author:
Neil Osterweil
Publish date: January 22, 2021

Lockdown-related stress and psychological factors may play a role, but SARS-CoV-2 may also have still-unrecognized central nervous system effects...

  • Read More

News

Higher intensity therapy doesn’t increase surgical risk in esophageal cancer

Author:
Neil Osterweil
Publish date: January 20, 2021

Neither radiation nor docetaxel added to neoadjuvant cisplatin plus 5-fluorouracil increased the risk of perioperative complications when compared...

  • Read More

News

Boost dose reduces recurrence in high-risk DCIS

Author:
Neil Osterweil
Publish date: January 20, 2021

Adding a tumor bed boost to whole breast irradiation cut the risk of local recurrence in half, regardless of fractionation.

  • Read More

News

Von Willebrand disease guidelines address women’s bleeding concerns

Author:
Neil Osterweil
Publish date: January 19, 2021

In the absence of robust evidence, the joint guidelines outline key suggestions for clinical situations covering...

  • Read More

News

Bemarituzumab FIGHTs gastric/GEJ cancers, improving survival

Author:
Neil Osterweil
Publish date: January 19, 2021

Bemarituzumab improved progression-free and overall survival.

  • Read More

News

Four-item prognostic index predicts survival in adult Burkitt lymphoma

Author:
Neil Osterweil
Publish date: December 16, 2020

Patients with zero of four risk factors on the Burkitt Lymphoma International Prognostic Index had excellent 3-...

  • Read More

News

Study found dual-targeted CAR T highly active against relapsed/refractory multiple myeloma

Author:
Neil Osterweil
Publish date: December 15, 2020

Fifteen of 16 patients with relapsed/refractory multiple myeloma had strong responses to therapy with BCMA- and...

  • Read More

News

Adding atezolizumab to chemo doesn’t worsen QOL in early TNBC

Author:
Neil Osterweil
Publish date: December 14, 2020

After an initial decline, quality of life measures rebounded for patients treated with atezolizumab or placebo plus chemotherapy.

  • Read More

News

Pediatric regimens better for adolescents/young adults with aggressive B-cell NHL

Author:
Neil Osterweil
Publish date: December 10, 2020

The risk of relapse was more than fourfold higher for patients with DLBCL or Burkitt’s lymphoma treated at adult...

  • Read More

News

Diabetes prevention diet may lower mortality risk in breast cancer

Author:
Neil Osterweil
Publish date: December 10, 2020

Among participants in two iterations of the Nurses’ Health Study, healthier diets were linked to lower breast...

  • Read More

News

Emotions, worse attention linked to pain-related health care use in SCD

Author:
Neil Osterweil
Publish date: December 9, 2020

Poorly controlled emotions and poor cognitive test scores were predictors for sickle cell disease pain-related...

  • Read More

News

Childhood Hodgkin survivors have neurocognitive impairment

Author:
Neil Osterweil
Publish date: December 7, 2020

An analysis of survivors showed higher levels of impairment across four domains, but the difference may be...

  • Read More

News

Durable responses with anti-BCMA CAR T-cell for multiple myeloma

Author:
Neil Osterweil
Publish date: December 6, 2020

Seventy-two percent of patients with relapsed/refractory multiple myeloma had ongoing responses at the time of data cutoff in the CARTITUDE-1...

  • Read More

News

AASLD 2020: A clinical news roundup

Author:
Neil Osterweil
Publish date: November 25, 2020

A panel of reviewers highlighted abstracts from the digital edition of the 2020 Liver Meeting in the annual Clinical News Debrief.

  • Read More

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »

Privacy Policy

Do Not Sell My Personal Information

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close